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Background: Coping style is one of the determinants of health-related quality of life after stroke. Stroke patients
make less use of active problem-oriented coping styles than other brain damaged patients. Coping styles can be
influenced by means of intervention. The primary aim of this study is to investigate if Problem Solving Therapy is
an effective group intervention for improving coping style and health-related quality of life in stroke patients. The
secondary aim is to determine the effect of Problem Solving Therapy on depression, social participation, health care
consumption, and to determine the cost-effectiveness of the intervention.
Methods/design: We strive to include 200 stroke patients in the outpatient phase of rehabilitation treatment, using
a multicenter pragmatic randomized controlled trial with one year follow-up. Patients in the intervention group will
receive Problem Solving Therapy in addition to the standard rehabilitation program. The intervention will be
provided in an open group design, with a continuous flow of patients. Primary outcome measures are coping style
and health-related quality of life. Secondary outcome measures are depression, social participation, health care
consumption, and the cost-effectiveness of the intervention.
Discussion: We designed our study as close to the implementation in practice as possible, using a pragmatic
randomized trial and open group design, to represent a realistic estimate of the effectiveness of the intervention. If
effective, Problem Solving Therapy is an inexpensive, deliverable and sustainable group intervention for stroke
rehabilitation programs.
Trial registration: Nederlands Trial Register, NTR2509
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Stroke is an increasing public health problem in the
Netherlands: every year, 41,000 people suffer from stroke
and over 3% of the total health care costs are related to
the treatment of stroke and its consequences [1]. The
mortality rate after stroke is 30% and is likely to de-
crease, which will cause an increase in morbidity [2]. Al-
most 50% of stroke survivors experience consequences
in daily life that result in a lowered health-related quality* Correspondence: mvisser@rijndam.nl
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reproduction in any medium, provided the orof life (HR-QoL) [1]. The World Health Organization
Quality of Life (WHOQOL) Group defines quality of life
as “individuals’ perceptions of their position in life in the
context of the culture and value systems in which they
live and in relation to their goals, expectations, standards
and concerns [3]. HR-QoL refers to the health-related
aspects of quality of life. On average, utility scores of
HR-QoL after stroke range from 0.47 to 0.68 (a utility
score equal to death is 0.0 and full health 1.0), which is
substantially lower than the value of a healthy reference
population (utility score of 0.93) [4,5]. HR-QoL after
stroke is predicted by functional constraints, age, gender,
and psychosocial factors, like socioeconomic status, de-
pression, and coping style [4,6-8]. Functional constraints,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ficult to change, but coping style could be targeted. The
question then becomes if HR-QoL after stroke could be
improved through a coping style intervention. If this is
possible, a secondary question would be how such im-
provement relates to depression, health care consump-
tion, and costs.
A common definition of coping style is someone’s pre-
ferred way of dealing with different situations. Several
coping styles can be distinguished, such as active, pas-
sive, and avoidant coping. Wolters (2010) shows that in
traumatic brain-injured (TBI) patients, higher HR-QoL
in the long term is predicted by an increase in active
problem-focused coping style and a decrease in passive
emotion-focused coping style. Unfortunately, in this
population of TBI patients the active coping decreases
over time, while passive coping increases [9]. This sug-
gests that if the decrease of active coping can be
stopped, there is room for improvement in HR-QoL.
Stroke patients make even less use of active, problem-
oriented coping styles compared to other brain damaged
patients [10]. Furthermore, Darlington (2007) shows that
in stroke patients, coping becomes more important in
determining HR-QoL over time, while the importance of
general functioning decreases [11]. This would mean
that long term HR-QoL could benefit from improved
coping.
Coping styles can be influenced by several interven-
tions. Backhaus (2010) shows that an intervention aimed
at changing maladaptive coping styles positively
influenced psychosocial functioning of TBI patients [12].
However, HR-QoL was not measured in this study. No
research is found that investigated an intervention aimed
at improving HR-QoL through the change of maladap-
tive coping styles in stroke patients. We therefore set
out to investigate whether Problem Solving Therapy
(PST), which aims at active problem-focused coping,
might improve HR-QoL in stroke patients. PST has been
proved effective in other patient populations [13,14]. In
stroke patients, PST has been shown successful for the
prevention of post stroke depression [15]. Effects on
coping style and HR-QoL have not been investigated yet.
Objectives
The primary aim of this study is to investigate whether
PST is an effective group intervention for improving ac-
tive problem-focused coping style and HR-QoL in stroke
patients. The secondary aim is to determine the effect of
PST on depression, social participation, health care con-
sumption, and the cost-effectiveness of the intervention.
The effectiveness of the therapy will be investigated in
an open group design, which has not been used in PST
research before. PST will be added to the standard care
just before the end of the rehabilitation program, as atthis moment a relapse in HR-QoL is frequently ob-
served, when patients cannot rely on their therapists
anymore [16]. By teaching patients to actively cope with
stressful situations, through adapting and realizing their
goals, we expect that patients will use more effective
coping styles, which consequently may prevent the re-
lapse in HR-QoL, and possibly increase HR-QoL in the
long term. With regard to the secondary aims of this
study, we expect the incidence of depression to decrease,
social participation to improve, and health care con-
sumption to decrease, resulting in a favorable cost-
effectiveness ratio for the intervention.
Methods/design
Study design and procedure
The effectiveness of PST for stroke patients will be eval-
uated in a multicenter pragmatic randomized controlled
trial (RCT) with one year follow-up, with the interven-
tion performed in the daily practice of a sub-acute out-
patient stroke rehabilitation program. As such, the
potential effects of the intervention have a good external
validity, which allows us to calculate the cost-
effectiveness of the therapy compared with standard
care.
The study will be performed in Rijndam Rehabilitation
Center in collaboration with Erasmus MC, both in the
Netherlands, and in Ghent University Hospital in
Belgium. Patients are invited by their rehabilitation phys-
ician to participate in the study. Before the start of the
study, patients need to sign the informed consent form.
Data will be collected at four time points by one of three
research psychologists. T0 is the baseline measurement,
performed within three weeks before the start of the
intervention phase. T1 will be performed within ten days
after the intervention phase, T2 six months and T3
twelve months after the intervention phase (Figure 1).
The measurements will be performed in the rehabilita-
tion center or at the patients’ home in a face-to-face
interview. The study has been approved by the Medical
Ethics Committee of Erasmus MC University Medical
Center and the Ethics Committee of Ghent University
Hospital.
Study population
We strive to include 200 stroke patients. Inclusion cri-
teria are: stroke (including subarachnoid hemorrhage),
age between 18 and 75 years, being treated in the out-
patient rehabilitation phase, and being able to participate
in group therapy. Exclusion criteria are: progressive
neurological disorders, life expectancy less than one year,
insufficient understanding of the Dutch language, exces-
sive drinking or drug abuse, subdural hematomas, mod-
erate and severe aphasia. The same criteria would apply
to the implementation of PST in practice, which stresses
Referral of patients, inclusion criteria:
- Stroke (including subarachnoid hemorrhage)
- Between 18 and 75 years of age
- Being treated in the outpatient rehabilitation phase
- Being able to follow the group therapy
Inclusion of patients:
- Rehabilitation physician provides information to patient
- Signed informed consent
Baseline measurement
Randomization
Intervention group
(standard care + PST)
Control group
(standard care)
T1 measurement
(8 weeks after T0)
T1 measurement
(8 weeks after T0)
T2 measurement
(6 months after T1)
T2 measurement
(6 months after T1)
T3 measurement
(12 months after T1)
T3 measurement
(12 months after T1)
Figure 1 Design of the randomized controlled trial.
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tients started March 2011 and will end August 2013.
The one-year follow-up of all patients will be finished by
September 2014.
Randomization
Patients are randomized to the intervention- or control
condition using a stratified block randomization proced-
ure with a block size of four. To ensure comparability
between the two groups, patients are stratified per re-
habilitation center. A member of the research group, who
is not involved in the collection of the data, prospectively
allocates the patients to the intervention- or control con-
dition in a one-to-one ratio using an online random-
number generator. To allow blinded randomization, the
allocation information will be put in separate sealed enve-
lopes which are consecutively numbered. At the end of
the baseline measurement, the investigator opens thenumbered envelop and informs the patient about the con-
dition he or she is assigned to. The research psychologists
who perform the baseline and follow-up measurements
are blinded for treatment condition. The therapists who
provide the intervention are not involved in the collection
of the data. The investigator who will analyze the data is
not involved in the collection of the follow-up
measurements.
Intervention: problem solving therapy
Patients who are assigned to the intervention condition
will receive PST in addition to the standard rehabilita-
tion program, which will start during the last eight
weeks of outpatient treatment. PST is a widely used and
practical intervention method, based on a general model
of coping with stress [17,18]. The model states that hav-
ing a chronic disease causes stressful daily problems,
which increase the chance of experiencing psychological
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is to improve the skills to cope with the stressful daily
problems in life after stroke.
The intervention will be provided in an open group
design, with a continuous flow of patients, which means
that patients can enter the group every week and leave
the group after eight sessions (Figure 2). The reason for
this design is that it studies group therapy in its most
feasible form, where patients start and end their pro-
grams at different time-points. If we had chosen to study
the effect in closed groups, many patients in the similar
stage of their programs are necessary. This would only
be possible if patients are admitted to large scale re-
habilitation centers, which is not the rehabilitation prac-
tice in The Netherlands, or patients would have to wait
for a long time before entering the group. The open
group design has some disadvantages. Patients may feel
unsafe when they enter an already existing group. Fur-
thermore, a continuous flow of patients is required to
keep a balanced number of patients in the group. There-
fore, interventions aimed at rare diseases cannot be
studied with an open group design. However, for our
population of stroke patients we do expect the design to
be suitable and beneficial, because these patients are fre-
quently seen in rehabilitation treatment. An open group
design has several benefits as well. Advantages for the
patients are that they do not have to wait until they can
start with the intervention, they can share their experi-
ences with other ‘experienced’ stroke patients, and there
is room for interaction with many fellow patients. Other
advantages are that the intervention is relatively easy to
organize and implement in the daily practice of the re-
habilitation center. This open group design has not been
investigated in PST research yet.
The intervention in this study consists of eight group
sessions of 1,5 hours a week, with homework exercises
after each session. The group consists of a minimum of
three and a maximum of six participants. PST is pro-
vided by one to three trained neuropsychologists per re-
habilitation center. Solving problems will be structured,
by dividing the problem solving process in four steps:
1. Define problem and goal;
2. Generating multiple solutions;Figure 2 Patient flow in an open group therapy.3. Considering the possible consequences of the
solutions systematically and select the best solution;
4. Implement the solution and evaluate.
Each session starts with the sharing of experiences
from the past week. Then, the model of problem solving
will be repeated and explained. If there are some partici-
pants who are in the group for a couple of weeks
already, they will be asked to explain the model to other
new participants. Subsequently, one step of the model
will be highlighted every week. With emphasis on this
specific step, the model will be applied to one or more
examples from the participants. Finally, the participants
will be asked to practice the specific step at home by
making a homework assignment. During the sessions,
inadequate and irrational thoughts will be challenged by
common cognitive interventions. A unique aspect of the
intervention is the focus on the definition of the prob-
lem in the first step of the model. A clear definition of
the problem will lead to a better understanding and
more solutions to it.
Control condition: standard care
Patients who are assigned to the control condition will
receive the standard rehabilitation program, in order to
be able to study the additional effect of the intervention
to the standard rehabilitation program. This standard re-
habilitation program consists of individualized amounts
of treatment by a physical therapist, occupational ther-
apist, speech therapist, psychologist, social worker, and
rehabilitation physician, depending on the severity of
stroke. On average, stroke patients in outpatient re-
habilitation receive twelve hours of treatment a week
during a nine week rehabilitation program.
Outcomes
Primary outcome measures are changes in task-oriented
coping and psychosocial HR-QoL in patients in the
intervention group in comparison with the control
group. Coping style is measured using the Coping Inven-
tory for Stressful Situations (CISS) and the short version
of the Social Problem Solving Inventory-Revised (SPSI-
R:SF). The CISS questionnaire consists of 48 questions
and contains three subscales; Task-oriented coping,
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subscale Avoidant coping consists of two subscales; Dis-
traction and Social Diversion [18,19]. Because the PST
aims at tasks, ‘Task-oriented coping’ is chosen as a pri-
mary endpoint; the other two subscales are used as sec-
ondary endpoints. The SPSI-R:SF questionnaire consists
of ten questions about problem solving skills regarding
daily situations. There are five subscales: Positive Prob-
lem Orientation, Rational Problem Solving, Negative
Problem Orientation, Impulsivity/Carelessness Style, and
Avoidance Style, and all are used as secondary endpoints
in this trial [20].
HR-QoL is measured using the EuroQol (EQ-5D-5L)
and the Stroke Specific Quality of Life Scale (SS-QoL-12).
The EQ-5D is a generic questionnaire, and consists of five
questions regarding mobility, self-care, daily activities,
pain/complaints, mood, and a VAS scale. The five dimen-
sions can be combined to one utility scale, representing
the societal perspective of the general public [21]. The SS-
QoL-12 is specifically developed for the population of
stroke patients [22]. We will use the abbreviated version
containing twelve items, which has been shown valid [23].
The questionnaire provides a total score and two sub
scores: physical and psychosocial, of which the psycho-
social sub-score is defined as the primary endpoint. The
other HR-QoL scores are used as secondary endpoints.
Other secondary outcome measures are differences in
depression, social participation, and health care con-
sumption between patients in the intervention and con-
trol group. Additionally, the influence of cognitive
functioning, personality characteristics, aphasia, type of
stroke, side of stroke, level of functioning, and demo-
graphic characteristics on the outcomes will be assessed.
Finally, the cost-effectiveness of the intervention will be
calculated compared with standard care.
Depression is measured using the Center for Epidemi-
ologic Studies Depression Scale (CES-D). This question-
naire consists of twenty items concerning depression,
higher scores indicate more depressive symptoms [24].
Social participation is measured using the Impact on
Participation and Autonomy (IPA). The questionnaire
consists of five dimensions; Autonomy indoors, Family
role, Autonomy outdoors, Social life and relationships,
Work and education [25].
Health care consumption is measured using the
Trimbos Questionnaire for Costs association with Psy-
chiatric Illness (TiC-P). The questionnaire was devel-
oped for economic evaluation in mental health care, and
measures health care consumption and productivity
losses [26].
Sample size calculation
To determine the sample size for measuring differences
between the intervention- and control group in copingstyle and HR-QoL, we searched for comparable effect
sizes in the literature. With regard to coping style, there
was no data available for this calculation. With regard to
HR-QoL, Studenski (2005) measured an increase in HR-
QoL after a physical therapy for stroke patients, with a
long term effect size f ranging from 0.06 to 0.18 [27]. Be-
cause of the lack of more comparable data, we used this
data and carefully estimated the effect size f to be 0.08.
Considering the design of two groups and four repeated
measurements, an expected correlation of 0.70, an alpha
of 0.05, and a power of 0.80, we calculated a total re-
quired sample size of 132 patients based on the F-test.
Because potential drop out is estimated at 0.30, we will
strive to include 200 patients.
Statistical analyses
Demographic variables will be analyzed with an inde-
pendent sample T-test for continuous variables, the
Mann–Whitney U test for ordinal variables, and the chi-
square test for categorical variables. Linear Mixed
Models will be used to compare the repeated measure-
ments between treatment groups, taking into account
the correlation within and between subjects. We will
create models for all the primary and secondary out-
come variables, with time, group condition (intervention
or control), and the interaction between these variables
as predictors. Furthermore, we will control for variables
that are accidentally not equally distributed between the
two group conditions.
The cost-effectiveness of the intervention will be cal-
culated by counting all the medical and non-medical
costs, like productivity losses. The incremental cost-
effectiveness ratio will be calculated by dividing the
difference in total costs by the difference in quality-
adjusted life years (QALYs). These QALYs will be calcu-
lated based on the EQ-5D questionnaire. The economic
evaluation will be conducted according to the Dutch
guidelines [28] and includes multivariate probabilistic
sensitivity analyses. In the base case scenario the time
horizon will be one year. If the effect is still present at
one year follow up, a Markov model will be made to
model a longer time horizon.
Discussion
This study investigates the effect of PST on coping style
and HR-QoL in stroke patients. In addition, the effect
on depression, social participation, and health care con-
sumption will be investigated, as well as the cost-
effectiveness of the intervention. We will study the
effectiveness of PST as close to the implementation in
practice as possible, using a pragmatic trial design and
an open group therapy. Any pragmatic trial has limita-
tions; MacPherson (2004) argued that a pragmatic trial
design cannot be used to determine the specific
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may be possible that patients in the intervention group
show improvement caused by the extra attention they
receive and not so much by the assumed effective ele-
ments of the therapy; this attention effect may be con-
sidered a placebo effect. If we would like to distinguish
between this ‘placebo effect’ and the effect of the specific
treatment elements, the control group should have re-
ceived a ‘sham therapy’. Such sham therapy would hin-
der the estimation of the effect of PST in practice, as in
practice such additional effort would not take place.
Therefore, one of the advantages of the pragmatic study
design is that the external validity is better than using a
sham-controlled design; the results will be generalizable
to the normal rehabilitation setting [30]. The study
population represents the normal stroke population in
the outpatient phase of rehabilitation treatment, and the
psychologists will provide the intervention to the pa-
tients just as they would do in practice. The results of a
pragmatic trial are directly applicable to the usual care
setting [31]. Moreover, if the intervention will prove ef-
fective, it will be easy to implement the intervention in
the standard rehabilitation program, since it is already in
use and the psychologists will already be trained. Other
rehabilitation centers can use the therapy manual we
developed.
We expect that patients who received PST will use
more effective coping styles and experience a higher
HR-QoL. Furthermore, we expect that patients after PST
will show a decrease in depression score, an increase in
social participation, and a decrease in health care con-
sumption, which would lead to a reduction in the health
care costs. We expect the intervention to be cost-
effective, since the costs of the intervention are relatively
low; one psychologist can train three to six patients at
the same time. Darlington (2009) estimated the cost-
effectiveness of an intervention aimed at coping strat-
egies in stroke patients: the maximum costs for a single
patient were 2500 euros, which will be lower if the ther-
apy is provided in a group [32]. If PST will be proved ef-
fective for stroke patients in outpatient rehabilitation,
the intervention will be an inexpensive, deliverable and
sustainable group intervention that could be added to
usual stroke rehabilitation programs.
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